Physician profile
Kyle Williams
NPI 1528468121
$580.48
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.45 · 2022: $162 · 2023: $228 · 2024: $97.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $172.60 | 2023 | Octrode, Proclaim |
| Ferring Pharmaceuticals INC. | $90.26 | 2021-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $67.87 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $65.25 | 2022 | |
| Saluda Medical Americas, INC. | $49.64 | 2024 | Evoke |
| Pacira Therapeutics, INC. | $30.25 | 2021 | |
| Ethicon US, LLC | $24.65 | 2024 | Surgicel Nu-Knit, Vistaseal, Stratafix |
| Pacira Pharmaceuticals Incorporated | $23.60 | 2024 | Iovera, Exparel, Zilretta |
| Bioventus LLC | $21.32 | 2022 | |
| Avanos Medical | $20.78 | 2021 | |
| Zimvie INC. | $14.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.